It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Abiomed Inc: "I have always felt that those guys would get the takeover bid, but it went to St. Jude. It's probably a little too expensive, but they've got a great mouse trap. As does Edwards Life Sciences, which is too big to be acquired."
Harman International Industries: "This company got hurt by the strong dollar and I think it is actually very cheap at $5.5 billion. But I've got to tell you, I understand that the quarters have been rocky. Dinesh [CEO] has to deliver."
Juno Therapeutics: "We don't do the clinical stages anymore. Remember they have gotten way too difficult. We prefer if you do an anti-cancer franchise, it's JNJ or Bristol-Myers."